Chelation therapy for iron overload

James C Barton1

  • 1Southern Iron Disorders Center, G-105, 2022 Brookwood Medical Center Drive, Birmingham, AL 35243, USA. ironmd@dnamail.com

Insights

Iron overload causes organ damage, necessitating effective chelation therapy. New oral iron chelators offer improved management options for various iron overload conditions, including anemias and hemochromatosis.

Area of Science:

  • Hematology
  • Pharmacology
  • Internal Medicine

Background:

  • Iron overload leads to significant organ damage in the heart, liver, and endocrine glands.
  • Limited physiological mechanisms exist for iron excretion, making therapeutic intervention crucial.

Purpose of the Study:

  • To review current and emerging iron chelation therapies for managing iron overload.
  • To discuss therapeutic alternatives for patients with hereditary anemias and hemochromatosis.

Main Methods:

  • Review of licensed iron chelation drugs (parenteral and oral).
  • Assessment of ongoing clinical investigations for novel oral chelators.
  • Analysis of therapeutic strategies for diverse iron overload etiologies.

Main Results:

  • Three licensed iron chelation drugs are available: one parenteral and two oral.
  • Development and investigation of additional oral chelators are expanding treatment options.
  • Chelation therapy presents alternatives to phlebotomy for specific patient groups.

Conclusions:

  • Effective iron chelation is vital for preventing organ damage in iron overload disorders.
  • Emerging oral chelators enhance management strategies for beta-thalassemia major, sickle cell disease, and hemochromatosis.
  • Therapeutic advancements provide crucial alternatives for patients with various iron overload conditions.

Related Concept Videos

Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is formed in...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Complexation Equilibria: The Chelate Effect01:19

Complexation Equilibria: The Chelate Effect

In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...